Physicians who perform fluoroscopy-guided procedures are not at higher risk for cancer or death.
Physicians who perform fluoroscopy-guided interventional (FGI) procedures are not at higher risk for death from specific causes related to radiation risk compared with psychiatrists, according to a study published in Radiology.
Researchers from Maryland and Pennsylvania sought to compare the total and cause-specific mortality rates between physicians likely to have performed FGI procedures (FGI MDs) and psychiatrists to determine if any differences are consistent with known radiation risks. The researchers compared the mortality risks in nationwide cohorts of 45,634 FGI MDs and 64,401 psychiatrists. The cause of death was ascertained from the National Death Index.
During the follow-up from 1979 to 2008, 3,506 FGI MDs (86 women) and 7,814 psychiatrists (507 women) died. Male FGI MDs had lower totals compared with psychiatrists (men: RR, 0.80; women: RR, 0.80) and cancer (men: RR, 0.92; women: RR, 0.83) mortality. Mortality because of specific types of cancer, total and specific types of circulatory diseases, and other causes were not elevated in FGI MDs compared with psychiatrists. On the basis of small numbers, leukemia mortality was elevated among male FGI MDs who graduated from medical school before 1940.
The authors concluded that while more study is needed, overall total deaths and deaths from specific causes were not elevated in FGI MDs compared with psychiatrists.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.